Loading clinical trials...
Loading clinical trials...
Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen (ProDLBCL)
Conditions
Locations
39
Brazil
Hemocentro-Unicamp
Campinas, Brazil
Centro Medico
Santa Isabel, Brazil
Centro Paulista de Oncologia
São Paulo, Brazil
Santa Casa Medical School
São Paulo, Brazil
Clinica Ematologica Policlinico Carreggi
Florence, Firenze, Italy
Ematologia e Trapianto IRCCS, Istituto Nazionale dei Tumori
Milan, Milano, Italy
Start Date
May 1, 2009
Primary Completion Date
May 1, 2011
Completion Date
May 1, 2011
Last Updated
November 23, 2011
NCT04488354
NCT01897571
Lead Sponsor
Fondazione Italiana Linfomi - ETS
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions